If you are wondering whether Bristol-Myers Squibb is offering good value at around US$54.94 per share, you are not alone. Many investors are asking the same question right now. The stock has had mixed ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best High Yield Stocks to Buy. On January 7, UBS upgraded Bristol-Myers Squibb Company (NYSE:BMY) to a Buy from Neutral. The firm ...

Bristol Myers Squibb (BMY) is up ~27% in 3 months; learn why it’s now a Hold, key Eliquis replacement risks, and dividend ...

Bristol Myers Squibb (BMY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best undervalued wide moat stocks. On January 13, 2026, Leerink raised ...

Bristol Myers Squibb BMY highlighted the potential of its deep and promising pipeline at the 44th Annual J.P. Morgan ...

The Verdict: Janux Therapeutics’s Benzinga Edge signal reveals a classic ‘High-Flyer’ setup. While the Momentum (1.4) ...

As of Friday, January 23, Nektar Therapeutics’s NKTR share price has surged by 7.36%, which has investors questioning if this ...

Harbour BioMed exercises its warrant to buy Spruce Biosciences shares, raising its stake to about 3.8% as the companies work ...

Artificial intelligence may be all the rage in the technology sector, but it's also having a huge impact on healthcare.

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...